Savonix
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 California St Ste 1525, San Francisc...Phone Number
(877) 992-4724Website
www.assiststudy.orgRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Savonix
Founded in 2014 and headquartered in San Francisco, CA, Savonix Inc., is a developer of a mobile evidence-based digital neuro-cognitive assessment and brain health platform. The Savonix Digital Cognitive Assessment Platform empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes.Explore more
Savonix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Savonix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Savonix launches new products
Check out if Savonix is spiking on competitors!
Earning: See what the market has to say on Savonix recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Savonix
Click to see if Savonix had a recent Job posting/layoffs
Check if Savonix has recently received funding, and reach out quickly before it becomes old news!
Savonix, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Savonix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Savonix is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Savonix is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Savonix.
Savonix financials insights
Gather financial insights about Savonix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Angel/Seed
$1.5M
2019
Series A
$14.7M
2020
Debt
$350K
Savonix Tech Stack
A closer look at the technologies used by Savonix
Most Recent Scoops
Partnership
Partnership, Product Management, Sales Development
Funding
Savonix has received an SBA PPP loan for $350,000-1 million from Cross River Bank, supporting the retention of 18 jobs.
Event
Savonix recently attended the 2019 HLTH conference, which was held October 27-30, 2019 in Las Vegas, NV.
Events
New Hire
Executive Move
As previously reported, Jillian Kwan-Jacobs has assumed the role of Chief Operating Officer.
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Savonix News & Media
サボニックスと富士通コネクテッドテクノロジーズが提携し、らくらくスマートフォンF-42A向けのSavonix Mobileアプリを発表
サンフランシスコ--(BUSINESS WIRE)--（ビジネスワイヤ） -- デジタル・コグニティブヘルス検査の世界的リーダー企業であるサボニックスと、日本の大手スマートフォンメーカーの1つである富士通コネクテッドテクノロジーズ株式会社（FCNT）は、らくらくスマートフォンF-42A向けデジタルコグニティブ検査アプリのSavonix Mobile（サボニックス・モバイル）を発表しました。 日本では460万人以上が何らかの認知症に苦しんでおり、2025年までに全体で約730万人、つまり65歳以上の日本人5人に1人の割合に急増すると予想されています。日本政府は昨年、今後6年間にわたり70歳以上における認知症の症例を6%低減する目標を発表しました。 らくらくスマートフォンF-42Aにインストール済みのSavonix Mobileにより、ユーザーは実行機能・作業記憶・衝動制御など8つの脳機能について自分の認知機能を検査できます。ユーザーはアプリから直ちに検査結果を受け取り、自分の認知機能の健康を管理するための行動を取ることができます。Savonix Mobileは、93%の確率で軽度認知障Samenvatting: Savonix en Fujitsu Connected Technologies Limited Partner introduceren Savonix Mobile App op Raku-Raku Smartphone F-42A
SAN FRANCISCO--(BUSINESS WIRE)--Savonix, een wereldleider op het gebied van digitale cognitieve gezondheidstests, en Fujitsu Connected Technologies Limited (FCNT), een van de grootste smartphonefabrikanten in Japan, hebben Savonix Mobile – een digitale cognitieve testapp – onthuld op de Raku -Raku Smartphone F-42A. Meer dan 4,6 miljoen mensen in Japan lijden aan een vorm van dementie, en het totaal zal naar verwachting stijgen tot ongeveer 7,3 miljoen mensen – of een op de vijf Japanners van 65Savonix e Fujitsu Connected Technologies Limited fazem parceria para apresentar o Savonix Mobile App no smartphone Raku-Raku F-42A
SÃO FRANCISCO--(BUSINESS WIRE)--Savonix, um líder global em testes digitais de saúde cognitiva e Fujitsu Connected Technologies Limited (FCNT), um dos maiores fabricantes de smartphones no Japão, lançaram o Savonix Mobile - um aplicativo de teste cognitivo digital - no smartphone Raku-Raku F-42A. Mais de 4,6 milhões de pessoas no Japão sofrem de alguma forma de demência, com o total previsto para aumentar para cerca de 7,3 milhões de pessoas, ou um em cada cinco japonesesSavonix y Fujitsu Connected Technologies Limited Se Asocian para Presentar la Aplicación Savonix Mobile en el Teléfono Inteligente Raku-Raku F-42A
SAN FRANCISCO--(BUSINESS WIRE)--Savonix, líder mundial en pruebas de salud cognitiva digital, y Fujitsu Connected Technologies Limited (FCNT), uno de los principales fabricantes de teléfonos inteligentes del Japón, presentó Savonix Mobile, aplicación de pruebas cognitivas digitales en el teléfono inteligente Raku-Raku F-42A. Más de 4,6 millones de personas en el Japón padecen algún tipo de demencia, y se espera que el total aumente a, aproximadamente, 7,3 millones de personas, o uno de cada cin
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Savonix
Sign Up For FreeTo access detailed company insights
Founded in 2014 and headquartered in San Francisco, CA, Savonix Inc., is a developer of a mobile evidence-based digital neuro-cognitive assessment and brain health platform. The Savonix Digital Cognitive Assessment Platform empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcome... Read More
